Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aguado-Flor Ester, Reyes Victoria M, Navarro Víctor, Mollà Meritxell, Aguado-Barrera Miguel E, Altabas Manuel, Azria David, Baten Adinda, Bourgier Celine, Bultijnck Renée, Chang-Claude Jenny, De Santis Maria Carmen, Dunning Alison M, Duran-Lozano Laura, Elliott Rebecca M, Farcy Jacquet Marie-Pierre, Giandini Carlotta, Giraldo Alexandra, Green Sheryl, Lambrecht Maarten, Lopez-Pleguezuelos Carlos, Monten Chris, Rancati Tiziana, Rattay Tim, Rosenstein Barry S, De Ruysscher Dirk, Diez Orland, Seibold Petra, Sperk Elena, Symonds R Paul, Stobart Hilary, Vega Ana, Veldeman Liv, Villacampa Guillermo, Webb Adam J, Weltens Caroline, Zunino Paolo, Talbot Christopher J, West Catharine M, Giralt Jordi, Gutiérrez-Enríquez Sara, REQUITE consortium
Аннотация
METHODS: The study involved 1979 BC patients monitored for two to eight years post-RT in a multi-centre study. We assessed acute (oedema/erythema) and late (atrophy/fibrosis) toxicity using logistic regression and Cox proportional hazards models. The cohort was divided into training and validation datasets.
RESULTS: Six SNPs demonstrated to be predictors of acute (rs13116075, rs12565978, rs72550778 and rs7284767) and late toxicity (rs16837908 and rs61764370) either in the training or validation cohort. However, none of these SNPs were consistently associated with toxicity across both stages of analysis. The rs13116075, rs12565978 and rs16837908 were previously reported to be associated with RT toxicity. In the validation phase, SNP-based models showed limited predictive ability, with AUC values of 0.49 and c-index of 0.54 for acute and late toxicity, respectively. Models incorporating either clinical variables alone or in combination with SNPs achieved similar AUC and c-index values of ∼0.60 for acute and late toxicity, respectively. However, the combined model exhibited the highest predictive accuracy for acute and late toxicity, both in the training and the validation cohorts.
CONCLUSIONS: Our findings highlight the importance of combining clinical data with genetic markers to enhance the accuracy of models predicting RT toxicity in BC.